thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
thenewsfacts.comthenewsfacts.com
Font ResizerAa
Search
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
Follow US
© thenewsfacts : All Rights Reserved.

Home » COVAXIN now meets WHO safety profile – Soumya Swaminathan

COVID-19

COVAXIN now meets WHO safety profile – Soumya Swaminathan

TheNewsFacts
Last updated: July 9, 2021 11:34 am
TheNewsFacts
Share
COVAXIN now meets WHO safety profile - Soumya Swaminathan
SHARE

The desi vaccine developed by Bharat Biotech got a huge boost when the Chief Scientist at WHO said that the Indian COVID Vaccine COVAXIN meets the safety profile of the International Health Organisation.

This also silences the critics and instill great promise for Hyderabad-based vaccine Dr. Krishna Ella’s Bharat Biotech, to get nod for listing in World Health Organization (WHO) approved COVID vaccine. The company recently announced its Phase 3 trials conclusion demonstrating strong efficacy and protection against variants.

COVAXIN® Proven SAFE in India's Largest Efficacy Trial. Final Phase-3 Pre-Print Data Published on https://t.co/JJh9n3aB6V pic.twitter.com/AhnEg56vFN

— Bharat Biotech (@BharatBiotech) July 2, 2021

Soumya Swaminathan, the chief scientist at WHO told a Mumbai-based news organisation that the final phase trial data for Covaxin “looks good” and meets the safety profile of the international public health agency so far.

The pre-submission meeting between Bharat Biotech and WHO was held on June 23, Swaminathan told CNBC TV-18 in an interview, adding that the data packet is currently being assembled. She noted that although Covaxin’s efficacy against the Delta variant of Covid-19 is a bit low, it is still not bad, while the overall efficacy is “quite high.”

Bharat Biotech finally made public its findings from the Phase-3 efficacy analysis of Covaxin last Saturday, where it claimed an overall efficacy of 77.8% against symptomatic Covid-19 patients.

New data on Delta-Efficacy or Effectiveness (not🍎to🍎 comparison):

Pfizer: Wuhan=95% | Delta=64%
COVAXIN: Wuhan/Delta=78% | Delta=65%

All vaccines prevent >93% of hospitalizations. Regardless of the vaccine, get it, and wear a mask to get to near 100%.

— Dr. Raches Ella (@RachesElla) July 6, 2021

The pre-print data from “India’s largest efficacy trial” showed that Covaxin demonstrates 93.4% effectiveness against severe symptomatic Covid-19 cases. On the other hand, Covaxin provides 65.2% protection against the B.1.617.2 (Delta) strain, currently the most predominant Covid-19 variant in India, it said

Recently WHO chief said The world is at a perilous point in the #COVID19 pandemic. We have just passed the tragic milestone of 4 million recorded deaths, which likely underestimates the overall toll. It didn’t have to be this way and it doesn’t have to be this way going forward. #VaccinEquity

Share This Article
Email Copy Link Print
Previous Article Big Boss Sidharth Shukla slams reports of his split with Shenaaz Gill Big Boss Sidharth Shukla slams reports of his split with Shenaaz Gill
Next Article New Coach Rahul Dravid holds great promise for Indian Cricket - VVS Laxman New Coach Rahul Dravid holds great promise for Indian Cricket – VVS Laxman

Your Trusted Source for Accurate and Timely Updates!

We're committed to providing accurate and unbiased news as it unfolds, earning the trust of a large audience. Stay informed with our news updates on the latest events and trends, keeping you ahead of the curve.
FacebookLike
XFollow
InstagramFollow

Popular Posts

OYCHEF the New Foodie’s App to Book a Chef Whenever, Wherever

Hyderabad Startup OYCHEF has launched a unique private chef services app to deliver fine dining…

By
TheNewsFacts

Turkey Earthquake: Global Aid for Turkey, Syria; 4,000+ Casualties

Turkey Earthquake Update : A 5.6 magnitude earthquake struck central Turkey on Tuesday, only hours…

By
TheNewsFacts

Kantara Chapter 1 Breaks ₹439 Crore Barrier, Tops Box Office

October 13, 2025: Rishab Shetty’s Kantara Chapter 1 is on a box office rampage. In…

By
NewsFacts Bureau

You Might Also Like

Millions of Child Immunisation Doses disrupted due to Pandemic
COVID-19

Millions of Child Immunisation Doses disrupted due to Pandemic

By
TheNewsFacts
Has Sputnik V hit a 2nd Dose Production Problem in India?
COVID Vaccines

Has Sputnik V hit a 2nd Dose Production Problem in India?

By
TheNewsFacts
993 Adverse Vaccination Events Reported In The Past 5 Months
COVID-19

993 Adverse Vaccination Events Reported In The Past 5 Months

By
TheNewsFacts
Covid-19 'Tragic Milestone' in 2022 demands for more immunisation - Tedros
COVID-19

Covid-19 ‘Tragic Milestone’ in 2022 demands for more immunisation – Tedros

By
TheNewsFacts
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?